VEON Ltd. (NASDAQ:VEON) does about 5.79M shares in volume on a normal day but saw 7812143 shares change hands in Monday trading. The company now has a market cap of 2.57B USD and an enterprise value of about $11.20B. Its current market price is $1.42, marking a decrease of -1.39% compared to the previous close of $1.44. The 52 week high reached by this stock is $2.78 whilst the lowest price level in 52 weeks is $1.25. The script in recent trading has seen the stock touch a high of $1.4521 and a low of $1.32.
VEON Ltd. (VEON) has a 20-day trading average at $1.5380 and the current price is -48.92% off the 52-week high compared with 13.60% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.6706 and its 200-day simple moving average is $1.9495. If we look at the stock’s price movements over the week, volatility stands at 4.90%, which decreases to 3.27% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 23.23 to suggest the stock is oversold.
9 analysts observing the VEON Ltd. (VEON) stock have set the 12-month price targets for the company’s shares at between $1.70 and $2.20. The consensus objective for the share price is $2.31, suggesting that the stock has a potential upside of 38.53% over the period. The median price target is 23.24% away from the current levels at $1.85.
FactSet Research has provided data showing that 9 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 8 have advised that investors hold their positions. The consensus recommendation rating is Hold and Wall Street’s advice is for investors to Moderate Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on July 23, 2020 when UBS downgraded the stock to “Neutral” and issued a price target of . JP Morgan upgraded the stock to “Neutral” from Underweight on March 11, 2020 at a price target of $2.20.
The current price level is -8.45%, -15.29%, and -27.35% away from its SMA20, SMA50, and SMA200 respectively, with the VEON price moving above the 50-day SMA on August 31. VEON Ltd. (VEON) stock is down -7.19% over the week and -15.98% over the past month. Its price is -43.87% year-to-date and -45.59% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/29/2020, with the company’s earnings per share (EPS) of $0.05 above consensus estimates by $0.05. The company’s next earnings report is expected on 11/05/2020, with forecasts estimating quarterly EPS at $0.04 and $0.21 for whole year. VEON’s earnings per share are forecast to shrink by -46.20% this year and 28.60% over next year. Expected sales for next quarter are $2.1 billion, which analysts say will come at $8.13 billion for the current fiscal year and next year at $8.35 billion. In addition, estimates put the company’s current quarterly revenue at an average of $2.03 billion.
Its 12-month price target is $1.85. To reach the target analysts have set, the stock logically needs to grow 38.53 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $1.70, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $2.20.
Outstanding shares total 1.75B with insiders holding 56.17% of the shares and institutional holders owning 25.42% of the company’s common stock. The company has a return on investment of 13.10% and return on equity of 33.60%. The price to earnings ratio (P/E ratio) amounts to 7.72 while the forward price to earnings ratio is 5.28. The beta has a value of 1.28. Price to book ratio is 3.09 and price to sales ratio is 0.30.
According to a U.S. Securities and Exchange Commission filing, BNP Paribas Funds – Russia Equity has reduced its position in VEON Ltd. (VEON) to 20,877,607 shares, mirroring a recent drop by -11.52%. BNP Paribas Funds – Russia Equity dumped -2.72 million shares of VEON Ltd. common stock bringing its total worth to about $35.28 million at the end of recent close, SEC documents show. BNP Paribas Funds – Russia Equity isn’t the only investment manager who changed stakes and is followed by First Trust NASDAQ Technology Div, which sold off 0.0 shares to end up with 15,366,190 shares worth $25.97 million. BlackRock Strategic Fds – Emergi cut their holdings by -17.98% in the company over the course of the most recent quarter. It now holds a 0.53% position in VEON Ltd. thanks to 9.29 million shares amounting to $15.7 million.